Cited by 734SARS-CoV-2 and COVID-19 ResearchT-cell and B-cell ImmunologyCOVID-19 Clinical Research Studies

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Open access

Kaneko, Naoki, Kuo, Hsiao-Hsuan, Boucau, Julie, Farmer, Jocelyn R., Allard-Chamard, Hugues, Mahajan, Vinay S., Piechocka-Trocha, Alicja, Lefteri, Kristina, Osborn, Matthew, Bals, Julia, Bartsch, Yannic C., Bonheur, Nathalie, Caradonna, Timothy M., Chevalier, Josh, Chowdhury, Fatema, Diefenbach, Thomas J., Einkauf, Kevin, Fallon, Jon, Feldman, Jared, Finn, Kelsey K., Garcia-Broncano, Pilar, Hartana, Ciputra Adijaya, Hauser, Blake M., Jiang, Chenyang, Kaplonek, Paulina, Karpell, Marshall, Koscher, Eric C., Lian, Xiaodong, Liu, Hang, Liu, Jinqing, Ly, Ngoc L., Michell, Ashlin R., Rassadkina, Yelizaveta, Seiger, Kyra, Sessa, Libera, Shin, Sally, Singh, Nishant, Sun, Weiwei, Sun, Xiaoming, Ticheli, Hannah J., Waring, Michael T., Zhu, Alex L., Alter, Galit, Li, Jonathan Z., Lingwood, Daniel, Schmidt, Aaron G., Lichterfeld, Mathias, Walker, Bruce D., Yu, Xu G., Padera, Robert F., Pillai, Shiv·2020·Cell

DOI 10.1016/j.cell.2020.08.025PMC PMC7437499

Open this paper in CoChat — free account Open PDF

Abstract

Humoral responses in coronavirus disease 2019 (COVID-19) are often of limited durability, as seen with other human coronavirus epidemics. To address the underlying etiology, we examined post mortem thoracic lymph nodes and spleens in acute SARS-CoV-2 infection and observed the absence of germinal centers and a striking reduction in Bcl-6+ germinal center B cells but preservation of AID+ B cells. Absence of germinal centers correlated with an early specific block in Bcl-6+ T FH cell differentiation together with an increase in T-bet+ T H1 cells and aberrant extra-follicular TNF-α accumulation. Parallel peripheral blood studies revealed loss of transitional and follicular B cells in severe disease and accumulation of SARS-CoV-2-specific "disease-related" B cell populations. These data identify defective Bcl-6+ T FH cell generation and dysregulated humoral immune induction early in COVID-19 disease, providing a mechanistic explanation for the limited durability of antibody responses in coronavirus infections, and suggest that achieving herd immunity through natural infection may be difficult.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.cell.2020.08.025

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citation
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Antibody responses to SARS-CoV-2 in patients with COVID-19
Long, Q.-X., Liu, B.-Z., Deng, H.-J., Wu, G.-C., Deng, K., Chen, Y.-K., Liao, P., Qiu, J.-F., Lin, Y., Cai, X.-F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0897-1 · Cited by 2,876
Self-citation
Into the Eye of the Cytokine Storm
Tisoncik, J. R., Korth, M. J., Simmons, C. P., Farrar, J., Martin, T. R., & Katze, M. G. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05015-11 · Cited by 1,940
Germinal Centers
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Convergent Antibody Responses to SARS-CoV-2 in Convalescent Individuals
Robbiani, D. F., Gaebler, C., Muecksch, F., Lorenzi, J. C. C., Wang, Z., Cho, A., Agudelo, M., Barnes, C. O., Gazumyan, A., Finkin, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2456-9 · Cited by 1,853
T follicular helper cell differentiation, function, and roles in disease
Crotty, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.004 · Cited by 1,847
A serological assay to detect SARS-CoV-2 seroconversion in humans
Amanat, F., Stadlbauer, D., Strohmeier, S., Nguyen, T. H. O., Chromikova, V., McMahon, M., Jiang, K., Arunkumar, G. A., Jurczyszak, D., Polanco, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0913-5 · Cited by 1,769
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Ju, B., Zhang, Q., Ge, J., Wang, R., Sun, J., Ge, X., Yu, J., Shan, S., Zhou, B., Song, S., et al. (2020) · Nature · doi:10.1038/s41586-020-2380-z · Cited by 1,667 · cited 1×
“In persons with COVID-19, the magnitude and durability of antibody responses are greater in those with more severe disease (Ju et al., 2020; Amanat et al., 2020) but are often of low magnitude (Robbiani et al.”

Flagged first, then by citations

Show all 51 references

1 of the 51 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Woodruff, 2020, Critically ill SARS-CoV-2 patients display lupus-like hallmarks of extrafollicular B cell activation, medRxiv

Sorted by citations

Items 401–500 of 734

Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Autoimmunity 1 Year Later: The Era of Vaccines
Diamanti, A. P., Rosado, M. M., Nicastri, E., Sesti, G., Pioli, C., & Laganà, B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708848 · Cited by 11
Crohn’s and Colitis Canada’s 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: COVID-19 Vaccines—Biology, Current Evidence and Recommendations
Murthy, S. K., Kuenzig, M. E., Windsor, J. W., Ghia, J., Griffiths, A. M., Panaccione, R., Seow, C. H., Benchimol, E. I., Bernstein, C. N., Bitton, A., et al. (2021) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwab033 · Cited by 13
Intensity of Humoral Immune Responses, Adverse Reactions, and Post-Vaccination Morbidity after Adenovirus Vector-Based and mRNA Anti-COVID-19 Vaccines
Voulgaridi, I., Sarrou, S., Dadouli, K., Peristeri, A.-M., Nasika, A., Onoufriadis, I., Kyritsi, M. A., Anagnostopoulos, L., Theodoridou, A., Avakian, I., et al. (2022) · Vaccines · doi:10.3390/vaccines10081268 · Cited by 11
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 condition
Fischer, C., Willscher, E., Paschold, L., Gottschick, C., Klee, B., Diexer, S., Bosurgi, L., Dutzmann, J., Sedding, D., Frese, T., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00815-1 · Cited by 12
Germinal Center-Induced Immunity Is Correlated With Protection Against SARS-CoV-2 Reinfection But Not Lung Damage
Kim, G., Kim, D. H., Oh, H., Bae, S., Kwon, J., Kim, M., Lee, E., Hwang, E.-H., Jung, H., Koo, B., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab535 · Cited by 11
Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
Khanolkar, A. (2021) · Cells · doi:10.3390/cells11010067 · Cited by 12
Crosstalk between Platelets and SARS-CoV-2: Implications in Thrombo-Inflammatory Complications in COVID-19
Zhao, J., Xu, X., Gao, Y., Yu, Y., & Li, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814133 · Cited by 11
Engineered receptor binding domain immunogens elicit pan-sarbecovirus neutralizing antibodies outside the receptor binding motifPreprint
Hauser, B. M., Sangesland, M., Lam, E. C., Denis, K. S., Feldman, J. E., Yousif, A. S., Caradonna, T. M., Kannegieter, T., Balazs, A. B., Lingwood, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.07.415216 · Cited by 11
Self-citation
Severe COVID-19versusmultisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Fraser, R., Resendiz, A. O., Dockrell, D. H., Müller-Trutwin, M. C., & Mazein, A. (2023) · European Respiratory Review · doi:10.1183/16000617.0197-2022 · Cited by 11
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
Naiditch, H., Betts, M. R., Larman, H. B., Levi, M., & Rosenberg, A. Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1376654 · Cited by 10
Association of Juvenile Dermatomyositis Disease Activity With the Expansion of Blood Memory B and T Cell Subsets Lacking Follicular Markers
Gofshteyn, J. S., Mansfield, L. M., Spitznagle, J., Balasubramanian, P., Cardenas, J., Miller, T., Gu, J., Wang, X., Punaro, M., Fuller, J., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42446 · Cited by 10
Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles
Fong, C. C., Spencer, J., Howlett-Prieto, Q., Feng, X., & Reder, A. T. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1158487 · Cited by 11
SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2
Taefehshokr, N., Lac, A., Vrieze, A. M., Dickson, B. H., Guo, P. N., Jung, C., Blythe, E. N., Fink, C., Aktar, A., Dikeakos, J. D., et al. (2024) · Journal of Cell Science · doi:10.1242/jcs.262172 · Cited by 16
Genomic Intelligence as Über Bio-Cybersecurity: The Gödel Sentence in Immuno-Cognitive Systems
Markose, S. M. (2021) · Entropy · doi:10.3390/e23040405 · Cited by 10
Malignant hyperthermia susceptibility: cardiac histomorphometry of dogs and young and market-weight swine.
O'Brien, P. J., Fletcher, T. F., Metz, A. L., Kurtz, H. J., Reed, B. K., Rempel, W. E., Clark, E. G., & Louis, C. F. (1987) · PubMed Central · Cited by 10
Cellular pathways and molecular events that shape autoantibody production in COVID-19
Tsay, G. J., & Zouali, M. (2024) · Journal of Autoimmunity · doi:10.1016/j.jaut.2024.103276 · Cited by 9
Diverse domains of raspberry pectin: critical determinants for protecting against IBDs
Wu, D., Ye, X., Hu, W., Yu, C., Zhu, K., Pan, H., Chen, J., Cheng, H., & Chen, S. (2024) · Food & Function · doi:10.1039/d4fo03363a · Cited by 9
The CD38+HLA-DR+ T cells with activation and exhaustion characteristics as predictors of severity and mortality in COVID-19 patients
Long, Q., Song, S., Xue, J., Yu, W., Zheng, Y., Li, J., Wu, J., Hu, X., Jiang, M., Ye, H., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1577803 · Cited by 10
Self-citation
SARS-CoV-2 induced immune perturbations in infants vary with disease severity and differ from adults’ responses
Nehar-Belaid, D., Mejías, A., Xu, Z., Marcheş, R., Yerrabelli, R., Guo, C., Mertz, S. E., Ye, F., Sánchez, P. J., Tsang, J. S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59411-z · Cited by 9
CD4+ tissue‐resident memory T cells and their role in immunity
Kirkby, M., & Veldhoen, M. (2025) · Immunology and Cell Biology · doi:10.1111/imcb.70052 · Cited by 10
Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2
Changrob, S., Yasuhara, A., Park, S., Bangaru, S., Li, L., Troxell, C. A., Halfmann, P., Erickson, S. A., Catanzaro, N., Yuan, M., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20251146 · Cited by 9
The understanding of the immunopathology in COVID-19 infection
Taşçıoğlu, D. A., Akkaya, E., & Genç, S. (2021) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2021.1892817 · Cited by 9
Seltene Superinfektion bei einem COVID-19-Patienten – Eine Chronologie
Gamon, E., Tammena, D., Wattenberg, M., & Augenstein, T. (2021) · Der Anaesthesist · doi:10.1007/s00101-021-01018-2 · Cited by 9
Immunotherapy Summary for Cytokine Storm in COVID-19
Li, Y., Zhao, W., Liu, J., Chen, Z., Lv, Q., & Zhang, Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.731847 · Cited by 10
Self-citation
Detection and Predictors of anti-SARS-CoV-2 Antibody Levels in COVID-19 Patients at 8 Months After Symptom Onset
Guo, J., Li, L., Wu, Q., Li, H., Li, Y., Hou, X., Yang, F., & Qin, Z. (2021) · Future Virology · doi:10.2217/fvl-2021-0141 · Cited by 10
Abnormal Shift in B Memory Cell Profile Is Associated With the Expansion of Circulating T Follicular Helper Cells via ICOS Signaling During Acute HIV-1 Infection
Lu, X., Zhang, X., Cheung, A. K. L., Moog, C., Xia, H., Li, Z., Wang, R., Ji, Y., Xia, W., Liu, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.837921 · Cited by 10
Low quantity and quality of anti-spike humoral response is linked to CD4 T-cell apoptosis in COVID-19 patients
André, S., Azarias-da-Silva, M., Picard, M., Alleaume‐Butaux, A., Kundura, L., Cezar, R., Soudaramourty, C., Cruz, A. S., Mendes‐Frias, A., Carvalho, A., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05190-0 · Cited by 13
Characteristics and Roles of T Follicular Helper Cells in SARS-CoV-2 Vaccine Response
Chi, X., Gu, J., & Ma, X. (2022) · Vaccines · doi:10.3390/vaccines10101623 · Cited by 9
Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review
Venkat, R., Wallace, Z. S., & Sparks, J. A. (2023) · Current Rheumatology Reports · doi:10.1007/s11926-023-01111-y · Cited by 9
SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities
Marschalek, R. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810273 · Cited by 9
Antibodies, epicenter of SARS-CoV-2 immunology
Pecetta, S., Pizza, M., Sala, C., Andreano, E., Pileri, P., Troisi, M., Pantano, E., Manganaro, N., & Rappuoli, R. (2021) · Cell Death and Differentiation · doi:10.1038/s41418-020-00711-w · Cited by 9
INFECTION-ACQUIRED VERSUS VACCINE-INDUCED IMMUNITY AGAINST COVID-19
Velikova, T. V. (2021) · Central Asian Journal of Medical Hypotheses and Ethics · doi:10.47316/cajmhe.2021.2.1.05 · Cited by 9
Understanding COVID-19: From Dysregulated Immunity to Vaccination Status Quo
Escobedo, R. A., Singh, D. K., & Kaushal, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765349 · Cited by 10
Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immunity
Bauer, G., Struck, F., Staschik, E., Maile, J., Wochinz‐Richter, K., Motz, M., & Soutschek, E. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28006 · Cited by 7
SARS-COV-2 as an artificial creation: scientific arguments and counterarguments
Yee, S., Tan, C. S., Khan, A. H., Lee, K. S., Goh, B. H., & Ming, L. C. (2021) · Journal of Medicine and Life · doi:10.25122/jml-2020-0175 · Cited by 9
Preferential expansion upon boosting of cross-reactive “pre-existing” switched memory B cells that recognize the SARS-CoV-2 Omicron variant Spike proteinPreprint
Perugino, C. A., Liu, H., Feldman, J. E., Hauser, B. M., Jacob-Dolan, C., Nathan, A., Zhou, Z., Kaseke, C., Tano-Menka, R., Getz, M. A., et al. (2022) · medRxiv · doi:10.1101/2021.12.30.21268554 · Cited by 9
Self-citation
Cytomegalovirus-specific neutralizing antibodies effectively prevent uncontrolled infection after allogeneic hematopoietic stem cell transplantation
Wang, H., Liu, H., Zhou, L., Wang, D., Wang, S., Liu, Q., Wu, Y., Tu, M., Sun, Z., Zheng, X., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105065 · Cited by 8
Self-citation
Assessing organ-level immunoreactivity in a rat model of sepsis using TSPO PET imaging
Martínez‐Orengo, N., Tahmazian, S., Lai, J., Wang, Z., Sinharay, S., Schreiber-Stainthorp, W., Basuli, F., Maric, D., Reid, W. C., Shah, S., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010263 · Cited by 8
COVID-19, Epstein-Barr virus reactivation and autoimmunity: Casual or causal liaisons?
Tarasco, M. C., Iacomino, N., Mantegazza, R., & Cavalcante, P. (2025) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2025.03.014 · Cited by 8
Tumor-infiltrating B cells produce tumor-specific antibodies and may contribute to suppressing tumor in head and neck squamous cell carcinoma
Sameshima, J., Chen, H., Kaneko, N., Yan, L., Yokomizo, S., Sueyoshi, T., Nagano, H., Sakamoto, T., Tanaka, S., Maruse, Y., et al. (2025) · OncoImmunology · doi:10.1080/2162402x.2025.2543019 · Cited by 8
Self-citation
A Minimalist Strategy Towards Temporarily Defining Protection for COVID-19
Cimolai, N. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00533-4 · Cited by 8
The cytokine storm—An appropriate, over‐reactive response to SARS‐CoV‐2 or the wrong immune pathway?
Bellgrau, D., & Modiano, J. F. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12979 · Cited by 8
Interplay between Neutrophils, NETs and T-Cells in SARS-CoV-2 Infection—A Missing Piece of the Puzzle in the COVID-19 Pathogenesis?
Niedźwiedzka‐Rystwej, P., Grywalska, E., Hrynkiewicz, R., Bębnowska, D., Wołącewicz, M., Majchrzak, A., & Parczewski, M. (2021) · Cells · doi:10.3390/cells10071817 · Cited by 8
High interleukin-6 levels induced by COVID-19 pneumonia correlate with increased circulating follicular helper T cell frequency and strong neutralization antibody response in the acute phase of Omicron breakthrough infection
Kawasuji, H., Morinaga, Y., Nagaoka, K., Tani, H., Yoshida, Y., Yamada, H., Takegoshi, Y., Kaneda, M., Murai, Y., Kimoto, K., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1377014 · Cited by 8
Exponential decline, ceiling effect, downregulation, and T-cell response in immunoglobulin G antibody levels after messenger RNA vaccine boosters: a case report
Hirano, H., & Asada, H. (2024) · Journal of Medical Case Reports · doi:10.1186/s13256-024-04889-2 · Cited by 8
SARS-CoV-2 associated Complement genetic variants possibly deregulate the activation of the Alternative pathway affecting the severity of infection
Tsiftsoglou, S. A. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.03.021 · Cited by 8
Metabolic Landscape of Bronchoalveolar Lavage Fluid in Coronavirus Disease 2019 at Single Cell Resolution
Shao, M., Shi, M., Du, J., Pei, X., Gu, B.-B., & Yi, F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.829760 · Cited by 8
Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
Newell, K. L., Waldran, M. J., Thomas, S. J., Endy, T. P., & Waickman, A. T. (2022) · Cytometry Part A · doi:10.1002/cyto.a.24563 · Cited by 8
T helper cell subsets and related target cells in acute COVID-19
Kudryavtsev, I. V., Головкин, А. С., & Тотолян, А. А. (2022) · Russian Journal of Infection and Immunity · doi:10.15789/2220-7619-thc-1882 · Cited by 8
Dissection of the Active Ingredients and Potential Mechanism of Han-Shi-Yu-Fei-Decoction in Treating COVID-19 Based on In Vivo Substances Profiling and Clinical Symptom-Guided Network Pharmacology
Jiao, G., Fan, X., Wang, Y., Weng, N., Ouyang, L., Wang, H., Pan, S., Huang, D., Han, J. H., Zhang, F., et al. (2022) · ACS Omega · doi:10.1021/acsomega.2c04589 · Cited by 8
Perturbations of immune landscape in COVID‐19 associated mucormycosis
Desai, N., Pradhan, V., Chougule, D., Tiwari, S., Mandke, C., Yadav, R. M., Athvale, A., Kawle, J., Pai, V., Pawaskar, S., et al. (2022) · Mycoses · doi:10.1111/myc.13546 · Cited by 8
Advances in Next-Generation Coronavirus Vaccines in Response to Future Virus Evolution
Li, L., Wei, Y., Han, Y., Yan, J., Li, X., Li, Z., Zhao, Y., Liang, H., & Wang, H. (2022) · Vaccines · doi:10.3390/vaccines10122035 · Cited by 8
Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma
Gong, L., Tian, J., Zhang, Y., Feng, Z., Wang, Q., Wang, Y., Zhang, F., Zhang, W., & Huang, G. (2022) · Annals of Surgical Oncology · doi:10.1245/s10434-022-12936-9 · Cited by 8
The single-cell landscape of immunological responses of CD4+ T cells in HIV versus severe acute respiratory syndrome coronavirus 2
Collora, J. A., Liu, R., Albrecht, K., & Ho, Y. (2020) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000655 · Cited by 8
Rationally designed immunogens enable immune focusing to the SARS-CoV-2 receptor binding motifPreprint
Hauser, B. M., Sangesland, M., Denis, K. S., Windsor, I. W., Feldman, J. E., Lam, E. C., Kannegieter, T., Balazs, A. B., Lingwood, D., & Schmidt, A. G. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.15.435440 · Cited by 8
Self-citation
Vaccine serologic responses among transplant patients associate with COVID-19 infection and T peripheral helper cellsPreprint
Lemieux, J. E., Li, A., Gentili, M., Perugino, C. A., Weiss, Z., Bowman, K. A., Ankomah, P., Liu, H., Lewis, G. D., Bitar, N., et al. (2021) · medRxiv · doi:10.1101/2021.07.11.21260338 · Cited by 8
Self-citation
Lympho-myeloid aggregate-infiltrating CD20+ B cells display a double-negative phenotype and correlate with poor prognosis in esophageal squamous cell carcinoma
Huang, Q., Wang, G., Zhang, Y.-M., Zhang, C., Ran, Y.-Q., He, J., Wang, G., Xu, X., Wang, S., Wu, J., et al. (2024) · Translational research · doi:10.1016/j.trsl.2024.11.002 · Cited by 7
Congenital T-cell activation impairs transitional-to-follicular B-cell maturation in humans
Allard‐Chamard, H., Hillier, K., Ramseier, M. L., Bertocchi, A., Kaneko, N., Premo, K. R., Lam, T., Yuen, G. J., Karpel, M., Mahajan, V. S., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2024013267 · Cited by 7
Self-citation
eIF3a function in immunity and protection against severe sepsis by regulating B cell quantity and function through m6A modification
Ouyang, Q., Cui, J., Wang, Y., Liu, K., Zhan, Y., Zhuo, W., Chen, J., Zhou, H.-H., Luo, C., Xia, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.02.005 · Cited by 7
The role of double-negative B cells in the pathogenesis of systemic lupus erythematosus
Qiu, X., Wen, R., Wu, F., Mao, J., Azad, T., Wang, Y., Zhu, J., Zhou, X., Xie, H., Hong, K., et al. (2025) · Autoimmunity Reviews · doi:10.1016/j.autrev.2025.103821 · Cited by 7
Critical Presentation of a Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection: A Case Report
Massanella, M., Martín-Urda, A., Mateu, L., Marín, T., Aldás, I., Riveira‐Muñoz, E., Kipelainen, A., Jiménez‐Moyano, E., de la Concepción, M. L. R., Ávila‐Nieto, C., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab329 · Cited by 7
When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak
Taoufik, Y., de Herve, M.-G. D. G., Corgnac, S., Dürrbach, A., & Mami‐Chouaib, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692598 · Cited by 7
Relevant of neutralizing antibody during SARS-CoV-2 infection and their therapeutic usage
Gupta, S. L., & Jaiswal, R. K. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07493-z · Cited by 7
Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?
Kara, E., Tanır, F., Demırhındı, H., Mete, B., Kibar, F., Çeti̇ner, S., Candevir, A., & İnaltekin, A. (2022) · Mikrobiyoloji Bulteni · doi:10.5578/mb.20229715 · Cited by 7
High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
Gupta, M., Balachandran, H., Louie, R. H. Y., Li, H., Agapiou, D., Keoshkerian, E., Christ, D., Rawlinson, W. D., Mina, M., Post, J. J., et al. (2022) · Immunology and Cell Biology · doi:10.1111/imcb.12607 · Cited by 7
Cellular mechanisms and clinical applications for phenocopies of inborn errors of immunity: infectious susceptibility due to cytokine autoantibodies
Sun, R., Wang, Y., & Abolhassani, H. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2208863 · Cited by 9
Immunologic Predictors of Vaccine Responsiveness in Patients With Lymphoma and Chronic Lymphocytic Leukemia
Chong, E. A., Kumashie, K. G., Chong, E. R., Fabrizio, J., Gupta, A., Svoboda, J., Barta, S. K., Walsh, K. M., Napier, E. B., Lundberg, R. K., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae106 · Cited by 7
In silico analysis suggests less effective MHC-II presentation of SARS-CoV-2 RBM peptides: Implication for neutralizing antibody responses
Castro, A., Öztürk, K., Zanetti, M., & Carter, H. K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246731 · Cited by 8
Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19
Bartlett, M. L., Suwanmanee, S., Akindele, N. P., Ghimire, S., Chan, A. K. P., Guo, C., Gould, S. J., Cox, A. L., & Griffin, D. E. (2022) · Viral Immunology · doi:10.1089/vim.2021.0191 · Cited by 7
The Evolution of Blood Cell Phenotypes, Intracellular and Plasma Cytokines and Morphological Changes in Critically Ill COVID-19 Patients
Berghäll, E., Hultström, M., Frithiof, R., Lipcsey, M., & Hahn‐Strömberg, V. (2022) · Biomedicines · doi:10.3390/biomedicines10050934 · Cited by 7
Transcriptome Analysis of Peripheral Blood Mononuclear Cells Response in Patients with Severe COVID-19 Reveals Crucial Genes Regulating Protein Ubiquitination
Huang, J., Li, R., Cheng, J., & Zhen, P. (2022) · Medical Science Monitor · doi:10.12659/msm.937532 · Cited by 8
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
Valenzuela-Fernández, A., Cabrera-Rodríguez, R., Ciuffreda, L., Pérez-Yanes, S., Estévez‐Herrera, J., González‐Montelongo, R., Alcoba-Flórez, J., Trujillo‐González, R., de Artola, D. G.-M., Gil-Campesino, H., et al. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1052436 · Cited by 8
A single dose of COVID-19 vaccine induces a strong T cell and B cell response in healthcare professionals recovered from SARS-CoV-2 infection
Laranjeira, P., Rodrigues, T., Silva, A., Barbosa, P., Reis, T., Lopes, C., Pinho, A. C. O., Silva, S., Silva, I., Carvalho, A., et al. (2022) · Clinical and Experimental Medicine · doi:10.1007/s10238-022-00801-8 · Cited by 6
The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
Wang, Y., Qin, T., & Ye, L. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.953022 · Cited by 7
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 InfectionPreprint
Haddad, N. S., Nguyen, D. C., Kuruvilla, M. E., Morrison-Porter, A., Anam, F. A., Cashman, K. S., Ramonell, R. P., Kyu, S. Y., Saini, A. S., Cabrera-Mora, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.04.410589 · Cited by 7
Had COVID? You’ll probably make antibodies for a lifetime
Callaway, E. (2021) · Nature · doi:10.1038/d41586-021-01442-9 · Cited by 7
Cytokine-driven PANoptosis of alveolar macrophages mediated by STAT1 underlies acute lung injury in hypervirulent Klebsiella pneumoniae infection
Xu, Q., Liu, X., Heng, H., Wang, H., Zhao, W., Luo, M., Yang, G., Peng, M., Chan, E. W., & Chen, S. (2026) · mBio · doi:10.1128/mbio.03958-25 · Cited by 7
A third SARS-CoV-2 mRNA vaccine dose in people receiving hemodialysis overcomes B cell defects but elicits a skewed CD4+ T cell profile
Sannier, G., Nicolas, A., Dubé, M., Marchitto, L., Nayrac, M., Tastet, O., Chatterjee, D., Tauzin, A., Lima-Barbosa, R., Laporte, M., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100955 · Cited by 6
Rapid Emergence of T Follicular Helper and Germinal Center B Cells Following Antiretroviral Therapy in Advanced HIV Disease
Wong, C.-S., Buckner, C. M., Lage, S. L., Pei, L., de Assis, F. L., Dahlstrom, E. W., Anzick, S. L., Virtaneva, K. I., Rupert, A. W., Davis, J. L., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.752782 · Cited by 6
Immunotherapy and CRISPR Cas Systems: Potential Cure of COVID-19?
He, X., & Zeng, X. X. (2022) · Drug Design Development and Therapy · doi:10.2147/dddt.s347297 · Cited by 7
Longitudinal Analysis of Biologic Correlates of COVID-19 Resolution: Case Report
Bruiners, N., Guerrini, V., Ukey, R., Dikdan, R. J., Yang, J. H., Mishra, P. K., Onyuka, A., Handler, D., Vieth, J. A., Carayannopoulos, M. O., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.915367 · Cited by 4
Can Probiotics, Particularly Limosilactobacillus fermentum UCO-979C and Lacticaseibacillus rhamnosus UCO-25A, Be Preventive Alternatives against SARS-CoV-2?
Valdebenito-Navarrete, H., Fuentes-Barrera, V., Smith, C. T., Salas-Burgos, A., Zuñiga, F. A., Gómez, L. A., & García, A. (2023) · Biology · doi:10.3390/biology12030384 · Cited by 7
It’s in the blood: a review of the hematological system in SARS-CoV-2-associated COVID-19
Harte, J. V., Coleman-Vaughan, C., Crowley, M. P., & Mykytiv, V. (2023) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2023.2232010 · Cited by 6
Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint
Alborghetti, M., Bellucci, G., Gentile, A., Calderoni, C., Nicoletti, F., Capra, R., Salvetti, M., & Centonze, D. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210330094017 · Cited by 6
Two-Step In Vitro Model to Evaluate the Cellular Immune Response to SARS-CoV-2
Melgaço, J. G., Azamor, T., da Silva, A. M. V., Linhares, J., Santos, T. P., Mendes, Y. S., de Lima, S. M. B., Fernandes, C. B., da Silva, J., de Souza, A. P., et al. (2021) · Cells · doi:10.3390/cells10092206 · Cited by 8
Corticosteroid treatment in COVID-19 modulates host inflammatory responses and transcriptional signatures of immune dysregulation
Pinski, A. N., Steffen, T. L., Zulu, M. Z., George, S. L., Dickson, A., Tifrea, D., Maroney, K. J., Tedeschi, N., Zhang, Y., Scheuermann, R. H., et al. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.4cova0121-084rr · Cited by 6
Longitudinal immune profiling of a SARS-CoV-2 reinfection in a solid organ transplant recipientPreprint
Klein, J., Brito, A. F., Trubin, P. A., Lu, P., Wong, P., Alpert, T., Peña-Hernández, M. A., Haynes, W. A., Kamath, K., Liu, F., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-405958/v1 · Cited by 6
Model-based cellular kinetic analysis of SARS-CoV-2 infection: different immune response modes and treatment strategiesPreprint
Zhou, Z., Zhao, Z., Shi, S., Wu, J., Li, D., Li, J., Zhang, J., Gui, K., Zhang, Y., Mei, H., et al. (2021) · medRxiv · doi:10.1101/2021.01.11.21249562 · Cited by 6
Self-citation
Lethal COVID-19 Associates With RAAS-Induced Inflammation For Multiple Organ Damage Including Mediastinal Lymph NodesPreprint
Guarnieri, J. W., Topper, M. J., Beigel, K., Haltom, J., Chadburn, A., Frere, J. J., An, J., Cope, H., Borczuk, A., Sinha, S., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.08.561395 · Cited by 6
A viral vaccine design harnessing prior BCG immunization confers protection against Ebola virus
Ng, T. W., Furuyama, W., Wirchnianski, A. S., Saavedra-Ávila, N. A., Johndrow, C. T., Chandran, K., Jacobs, W. R., Marzi, A., & Porcelli, S. A. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1429909 · Cited by 5
Melatonin as a complementary and prophylactic agent against COVID‐19 in high‐risk populations: A narrative review of recent findings from clinical and preclinical studies
Hosseini, A., Badri, T., Ghaleh, H. E. G., Hassanpour, K., Alishiri, G. H., Akbariqomi, M., & Farnoosh, G. (2022) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12805 · Cited by 5
Dysregulation of Innate and Adaptive Immune Responses in Asymptomatic SARS-CoV-2 Infection with Delayed Viral Clearance
Cao, S., Zhang, Q., Song, L., Xiao, M., Chen, Y., Wang, D., Li, M., Hu, J., Lin, L., Zheng, Y. Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.72963 · Cited by 5
Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2
Wei, X., Rong, N., & Liu, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.993754 · Cited by 6
Self-citation
SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection
Li, Z., Xiang, T., Liang, B., Liu, J., Deng, H., Yang, X., Wang, H., Feng, X., Zelinskyy, G., Trilling, M., et al. (2023) · Virologica Sinica · doi:10.1016/j.virs.2023.06.011 · Cited by 5
Self-citation
The guanine nucleotide exchange factor Rin-like controls Tfh cell differentiation via CD28 signaling
Sandner, L., Alteneder, M., Rîca, R., Woller, B., Sala, E., Frey, T., Tosevska, A., Zhu, C., Madern, M., Khan, M., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221466 · Cited by 5
Eicosanoids Signals in SARS-CoV-2 Infection: A Foe or Friend
Rahman, M. S., & Hossain, M. S. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00919-4 · Cited by 5
ATP-P2X7R pathway activation limits the Tfh cell compartment during pediatric RSV infection
Russo, C., Raiden, S., Algieri, S., Bruera, M. J., Carli, N. D., Sarli, M., Cairoli, H., Lillo, L. D., Morales, I., Seery, V., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1397098 · Cited by 5
The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
Dhawan, M. K., Thakur, N., Sharma, M. K., & Rabaan, A. A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.117936 · Cited by 5
COVID-19 and immunity: quo vadis?
Miyasaka, M. (2021) · International Immunology · doi:10.1093/intimm/dxab008 · Cited by 5
Peptides of H. sapiens and P. falciparum that are predicted to bind strongly to HLA-A*24:02 and homologous to a SARS-CoV-2 peptide
Adıgüzel, Y. (2021) · Acta Tropica · doi:10.1016/j.actatropica.2021.106013 · Cited by 5

Authors: Kaneko, N., Kuo, H.-H., Boucau, J., Farmer, J. R., Allard-Chamard, H., Mahajan, V. S., Piechocka-Trocha, A., Lefteri, K., Osborn, M., Bals, J., Bartsch, Y. C., Bonheur, N., Caradonna, T. M., Chevalier, J., Chowdhury, F., Diefenbach, T. J., Einkauf, K., Fallon, J., Feldman, J., Finn, K. K., Garcia-Broncano, P., Hartana, C. A., Hauser, B. M., Jiang, C., Kaplonek, P., Karpell, M., Koscher, E. C., Lian, X., Liu, H., Liu, J., Ly, N. L., Michell, A. R., Rassadkina, Y., Seiger, K., Sessa, L., Shin, S., Singh, N., Sun, W., Sun, X., Ticheli, H. J., Waring, M. T., Zhu, A. L., Alter, G., Li, J. Z., Lingwood, D., Schmidt, A. G., Lichterfeld, M., Walker, B. D., Yu, X. G., Padera, R. F., & Pillai, S.
Affiliations: Ragon Institute of MGH, MIT and Harvard (US)
Brigham and Women's Hospital (US)
Howard Hughes Medical Institute (US)
Harvard University (US)
Corresponding author: Padera, Robert F.
Pillai, Shiv
ORCID: Kaneko, Naoki
Kuo, Hsiao-Hsuan
Boucau, Julie
Farmer, Jocelyn R.
Allard-Chamard, Hugues
Mahajan, Vinay S.
Osborn, Matthew
Bals, Julia
Bartsch, Yannic C.
Caradonna, Timothy M.
Chevalier, Josh
Chowdhury, Fatema
Diefenbach, Thomas J.
Einkauf, Kevin
Fallon, Jon
Feldman, Jared
Garcia-Broncano, Pilar
Hartana, Ciputra Adijaya
Hauser, Blake M.
Jiang, Chenyang
Lian, Xiaodong
Liu, Hang
Michell, Ashlin R.
Rassadkina, Yelizaveta
Seiger, Kyra
Sessa, Libera
Shin, Sally
Singh, Nishant
Sun, Weiwei
Sun, Xiaoming
Waring, Michael T.
Zhu, Alex L.
Alter, Galit
Li, Jonathan Z.
Lingwood, Daniel
Schmidt, Aaron G.
Lichterfeld, Mathias
Walker, Bruce D.
Yu, Xu G.
Padera, Robert F.
Pillai, Shiv
Venue: Cell
Publisher: Elsevier BV
Published: 2020-10
Volume: 183
Issue: 1
Pages: 143-157.e13
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/j.cell.2020.08.025
PMC: PMC7437499
OpenAlex: W3049048202
Cited by: 734
References: 51
Citations by year: 2026: 31 · 2025: 48 · 2024: 69 · 2023: 105 · 2022: 174 · 2021: 244 · 2020: 62
FWCI: 19.19
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
Locations: Cell (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords: COVID-19 pandemic, SARS-CoV-2, BCL6, T follicular helper cells, germinal center, humoral immune response, T-bet, Th1 cells, TNF-α, transitional B cells, follicular B cells, spleen, herd immunity
MeSH terms: COVID-19, Aged, Aged, 80 and over, B-Lymphocytes, Female, T-Lymphocytes, Helper-Inducer, Humans, Male, Middle Aged, Pneumonia, Viral, Spleen, Tumor Necrosis Factor-alpha, Coronavirus Infections, Germinal Center, Proto-Oncogene Proteins c-bcl-6, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks